Just read this 2 news and see what you bros can conclude?
_____________________________________________________________
<TABLE cellSpacing=0 cellPadding=0 width="100%" border=0><TBODY><TR><TD>Ex-NMP suspended from medical practice
</TD></TR><TR><TD><!-- headline one : end --></TD></TR><TR><TD>Toh Keng Kiat failed to conduct key test before patient's chemotherapy </TD></TR><TR><TD><!-- show image if available --></TD></TR><TR vAlign=bottom><TD width=330>
</TD><TD width=10>
</TD><TD vAlign=bottom>
The omission by Dr Toh Keng Kiat led to a flare-up of the patient's hepatitis-B infection. He later died. -- PHOTO: LIANHE ZAOBAO
</TD></TR></TBODY></TABLE>
<!-- START OF : div id="storytext"--><!-- more than 4 paragraphs -->
A CONSULTANT haematologist has been suspended from practice for three months for failing to test a cancer patient for hepatitis-B ahead of chemotherapy.
Such a test is considered standard procedure, but the omission by Dr Toh Keng Kiat, a former Nominated Member of Parliament (NMP), led to a flare-up of the patient's hepatitis-B.
The patient died in May 2005.
Dr Toh's suspension took effect on Oct 30.
The patient, who had cancer of the lymph nodes, had consulted Dr Toh at his Camden Medical Centre clinic on Feb 3, 2005.
Without first testing for hepatitis-B, Dr Toh put the patient on chemotherapy between Feb 11 and April 26 that year, said a statement from the Singapore Medical Council (SMC) yesterday.
Hepatitis-B, which is endemic here, is a chronic viral infection that can lead to cirrhosis and liver cancer.
Dr Robert Lim, who heads the department of haematology-oncology at The Cancer Institute at the National University Hospital, explained that many cancer treatment regimens include significant doses of steroids, which have been linked to a higher risk of a flare-up of hepatitis-B, which in turn results in inflammation of the liver.
'This might lead to a compromise in liver function, or even death from liver failure. For that reason, we generally screen such patients for hepatitis-B to determine if they are carriers,' he said.
A cancer patient found to be a hepatitis-B carrier first has to be treated to control the replication of the hepatitis virus before being started on chemotherapy.
The patient in Dr Toh's case was eventually tested for hepatitis-B on May 12.
He was hospitalised at Gleneagles Hospital, but Dr Toh discharged him three days later, although his condition was serious and potentially life-threatening.
The patient died 14 days later, on May 26, of hepatitis-B, with his cancer, non-Hodgkin's lymphoma, as a contributing condition.
The patient's wife lodged a formal complaint against Dr Toh with the SMC three months later.
The SMC convened a disciplinary inquiry on Sept 28 and 29 this year.
Asked why it had taken four years for the case to be heard, an SMC spokesman told The Straits Times that the length of time taken depended on investigations, including the time taken to source medical experts and await their input.
Dr Toh pleaded guilty to two charges of failing to make an adequate evaluation of the patient's condition and to manage the hepatitis-B infection which developed during the chemotherapy.
Apart from the three-month suspension, the SMC also censured Dr Toh and ordered him to give a written undertaking that he would not engage in similar conduct.
He also had to make good on the expenses of the proceedings.
The council's spokesman said there was no prescribed penalty, as the facts in each case are different.
Dr Toh, who was an NMP between January 1992 and December 1996, is now overseas and could not be reached for comment.
_____________________________________________________________
<TABLE cellSpacing=0 cellPadding=0 width="100%" border=0><TBODY><TR><TD>Ex-NMP suspended from medical practice
</TD></TR><TR><TD><!-- headline one : end --></TD></TR><TR><TD>Toh Keng Kiat failed to conduct key test before patient's chemotherapy </TD></TR><TR><TD><!-- show image if available --></TD></TR><TR vAlign=bottom><TD width=330>
</TD><TD width=10>
The omission by Dr Toh Keng Kiat led to a flare-up of the patient's hepatitis-B infection. He later died. -- PHOTO: LIANHE ZAOBAO
</TD></TR></TBODY></TABLE>
<!-- START OF : div id="storytext"--><!-- more than 4 paragraphs -->
A CONSULTANT haematologist has been suspended from practice for three months for failing to test a cancer patient for hepatitis-B ahead of chemotherapy.
Such a test is considered standard procedure, but the omission by Dr Toh Keng Kiat, a former Nominated Member of Parliament (NMP), led to a flare-up of the patient's hepatitis-B.
The patient died in May 2005.
Dr Toh's suspension took effect on Oct 30.
The patient, who had cancer of the lymph nodes, had consulted Dr Toh at his Camden Medical Centre clinic on Feb 3, 2005.
Without first testing for hepatitis-B, Dr Toh put the patient on chemotherapy between Feb 11 and April 26 that year, said a statement from the Singapore Medical Council (SMC) yesterday.
Hepatitis-B, which is endemic here, is a chronic viral infection that can lead to cirrhosis and liver cancer.
Dr Robert Lim, who heads the department of haematology-oncology at The Cancer Institute at the National University Hospital, explained that many cancer treatment regimens include significant doses of steroids, which have been linked to a higher risk of a flare-up of hepatitis-B, which in turn results in inflammation of the liver.
'This might lead to a compromise in liver function, or even death from liver failure. For that reason, we generally screen such patients for hepatitis-B to determine if they are carriers,' he said.
A cancer patient found to be a hepatitis-B carrier first has to be treated to control the replication of the hepatitis virus before being started on chemotherapy.
The patient in Dr Toh's case was eventually tested for hepatitis-B on May 12.
He was hospitalised at Gleneagles Hospital, but Dr Toh discharged him three days later, although his condition was serious and potentially life-threatening.
The patient died 14 days later, on May 26, of hepatitis-B, with his cancer, non-Hodgkin's lymphoma, as a contributing condition.
The patient's wife lodged a formal complaint against Dr Toh with the SMC three months later.
The SMC convened a disciplinary inquiry on Sept 28 and 29 this year.
Asked why it had taken four years for the case to be heard, an SMC spokesman told The Straits Times that the length of time taken depended on investigations, including the time taken to source medical experts and await their input.
Dr Toh pleaded guilty to two charges of failing to make an adequate evaluation of the patient's condition and to manage the hepatitis-B infection which developed during the chemotherapy.
Apart from the three-month suspension, the SMC also censured Dr Toh and ordered him to give a written undertaking that he would not engage in similar conduct.
He also had to make good on the expenses of the proceedings.
The council's spokesman said there was no prescribed penalty, as the facts in each case are different.
Dr Toh, who was an NMP between January 1992 and December 1996, is now overseas and could not be reached for comment.